DCL: BODs Resolution on the company’s business plans in 2017
Based on Resolution No.03/NQ-HĐQT dated February 09, 2017, BODs of Cuu Long Pharmaceutical Joint Stock Company approved the company’s business plans in 2017 as follows:
No.
Target
Amount (VND)
1
Revenue
VND914,000,000,000
2
Gross profit
VND358,000,000,000
3
Profit after tax
VND96,000,000,000
HOSE
> BHS: Change of record date for right implementation (10/02/2017)
> TBC: The record date for 2017AGM (10/02/2017)
> LHG: Holding 2017AGM (10/02/2017)
> SGT: Holding 2017AGM (10/02/2017)
> SFI: Holding 2017AGM (10/02/2017)
> VNA: VNA stock likely to be delisted (10/02/2017)
> PTB: The record date for 2017AGM (10/02/2017)
> MSN: SSC allows MSN to raise the foreign ownership limit (10/02/2017)
> NTL: Board resolution on bank credit limit (13/02/2017)
> BHS: Notice of public offering (with new rights transfer period) (13/02/2017)
